Volume 10, 2023

Volume 10, 2023 is now on PubMed »

HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!

New method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing

Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

Think outside the box – atypical infections in chronic sinusitis

Cancer cell repopulation after therapy: which is the mechanism?

Transforming early cancer detection in primary care: harnessing the power of machine learning

Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer

Kinase-targeted therapy in subsets of colorectal cancer

Adenoid cystic carcinoma of the head and neck – treatment strategies of a highly malignant tumor with variable localizations

Squamous cell carcinoma of the oral cavity – follow up treatment and distant metastatic behavior

Cancer drug development yesterday, today and tomorrow

Lipiodol: from intrusion until exile from the tumor microenvironment

Exiting the pandemic together: achieving global immunity and equity

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

The mutational signatures of cancer: can passengers set a direction for prognosis?

Diagnosis and management of postoperative wound infections in the head and neck region

An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen

Be mindful of potential pitfalls when using the Cre-LoxP system in cancer research

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation